Δημοσιεύσεις σε Ιατρικά Περιοδικά (Pubmed)

l

“Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: A case report and review of the literature”.

G.Pavlakis, G.  Mountzios, , E. Terpos, A. Leivaditou, G. Papadopoulos, P. Papassavas 251 General Airforce Hospital, Medical Oncology Dpt, Athens, Greece.
Int J Gynecol Cancer
. 2006 Jan-Feb;16 Suppl 1:299-303.

l

“Concurrent Development of Testicular Seminoma and Choriocarcinoma of the Superior Mediastinum, Presented as Cervical Mass: A Case Report and Implications about Pathogenetic Mechanisms “ Giannis Mountzios,

Evangelos Terpos, George Sakorafas, Alexandra Leivaditou,George Papadopoulos, George Pavlakis, Evangelos Syrigos and Meletios-Athanasios Dimopoulos
251 General Airforce Hospital, Medical Oncology Dpt, Athens, Greece.
BMC Clin Pathol.
 2006 Nov 20;6(1):8

l

“Abnormal bone remodeling process is due to an imbalance in the Receptor Activator of Nuclear Factor–kB Ligand (RANKL)/Osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.

Giannis Mountzios, Meletios-Athanassios Dimopoulos, Aristotelis Bamias, George Papadopoulos, Efstathios Kastritis, Konstantinos Syrigos, George Pavlakis and EvangelosTerpos.
251 General Airforce Hospital, Medical Oncology Dpt and  University of Athens School of Medicine, “Alexandra” Hospital, Dpt. of Oncology.
Acta Oncol. 2007
;46(2):221-9.

l

“Advanced non-small-cell lung cancer: 'triplets' better than 'doublets'?”

Giannis Mountzios and Jean-Charles Soria Institut Gustave Roussy, Dpt of Medicine, Villejuif, France.
Nat Clin Pract Oncol.
 2006 Sep;3(9):476-7.

l

«ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer».

Olaussen KA, Mountzios G and Soria JC.
Curr Opin Pulm Med. 2007 Jul;13(4):284-9.

l

«Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma».

Handra-Luca A, Hernandez J, Mountzios G, Taranchon E, Lacau-St-Guily J, Soria JC, Fouret P.
Clin Cancer Res. 
2007 Jul 1;13(13):3855-9.

l

«Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model».

Mountzios G, Bamias A, Voulgaris Z, Rodolakis A, Vlahos G, Gourgoulis G, Papaiakovou EE, Giannopoulos A.
Gynecol Oncol
. 2008 Jan;108(1):130-5.

l

«Aurora kinases as targets for cancer therapy».

Mountzios G, Terpos E and Dimopoulos MA.
Cancer Treat Rev
. 2008 Apr;34(2):175-82.

l

«Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers».

Mountzios G, Planchard D, Besse B, Validire P, Girard P, Devisme C, Dimopoulos MA, Soria JC, Fouret P.
Clin Cancer Res
. 2008 Jul 1;14(13):4096-102.

l

«Mechanisms of Disease: signal transduction in lung carcinogenesis: a comparison of smokers and never-smokers».

Mountzios G, Fouret P, Soria JC.
Nat Clin Pract Oncol
. 2008 Oct;5(10):610-8.

l

«Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer».

Mountzios G, Dimopoulos MA, Papadimitriou C.
Biomark Insights. 2008 Apr 17;3:219-226

l

«Endocardial metastases as the only site of relapse in a patient with bladder carcinoma: A case report and review of the literature».

Mountzios G, Bamias A, Dalianis A, Danias P, Pantelidaki E, Nanas J, Dimopoulos MA. Int J Cardiol. 2008 Nov 29. [Epub ahead of print]

l

Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.

Taillade L, Penault-Llorca F, Boulet T, Fouret P, Michiels S, Taranchon
Mountzios G, Validire P, Domont J, Girard P, Grunenwald D, Le Chevalier T, Soria JC.
Ann Oncol. 2007 Jun;18(6):1043-50.

l

Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.

Mountzios G, Dimopoulos MA, Bamias A, Vourli G, Kalofonos H, Aravantinos G, Fountzilas G, Papadimitriou CA.
Ann Oncol. 2009 Aug;20(8):1362-8

l

«Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data».

Mountzios G, Dimopoulos MA, Soria JC, Sanoudou D, Papadimitriou CA.
Crit Rev Oncol Hematol. 2009 Nov 12. 
[Epub ahead of print]

l

«Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions»

Mountzios Giannis, Bamias Aristotelis, Koutsoukou Vassiliki, Anastasiou Ioannis, Stravodimos Konstantinos, Antoniou Nikolaos, Papadopoulos Georgios, Pavlakis Georgios, Papassavas Pantelis and  Dimopoulos Meletios-Athanasios.
J Cancer Res Clin Oncol. 
2009; 135: 1495-1500

l

«Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid».

Giannis Mountzios, Evangelos Terpos, Konstantinos Syrigos, Christos Papadimitriou, Giorgos Papadopoulos, Aristotelis Bamias, Μyron Μavrikakis and Meletios-Athanassios Dimopoulos.
J Transl Res 2009 Dec; [Epub ahead of print]

l

«Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature».

S. Murray, H. Linardou, G. Mountzios, M. Manoloukos, S. Markaki, E. Eleutherakis-Papaiakovou, N. Nikitas, M.-A. Dimopoulos, and C. A. Papadimitriou.
Mut Res 2009 Dec; [Epub ahead of print]

l

«Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrogen-mediated vasodilatation»

Vassilakopoulou M, Mountzios G, Papamechael C, Protogerou A D, Aznaouridis K, Katsichti P, Venetsanou K, Dimopoulos M-A, Ikonomidis I, Papadimitriou C A
Currently in press at J Pharm Sciences [January 2010]

l

«Developments in the systemic treatment of endometrial cancer»

Giannis Mountzios, Dimitrios Pectasides, Eftichia Kafantari, Eirini Pectasides, George Bozas, Meletios-A. Dimopoulos and Christos A. Papadimitriou
Crit Rev Oncol Hematol. 2011 Sep;79(3):278-92

l

«Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer».

Mountzios G, Kostopoulos I, Kotoula V, Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S, Angouridakis N, Vlachtsis K, Nikolaou A, Konstantinidis I, Fountzilas G.
PLoS One. 2013;8(1):e54048. doi: 10.1371/journal.pone.0054048. Epub 2013 Jan 24.

l

«Developments in the systemic treatment of metastatic cervical cancer».

Mountzios G, Soultati A, Pectasides D, Pectasides E, Dimopoulos MA, Papadimitriou CA.
Cancer Treat Rev. 2012 Jun 22. [Epub ahead of print]

l

«Bevacizumab in ovarian cancer.»

Mountzios G, Pentheroudakis G.
N Engl J Med. 2012 Mar 29;366(13):1257; author reply 1258.

l

«Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group».

Mountzios G, Emmanouilidis C, Vardakis N, Kontopodis E, Hatzidaki D, Popis E, Karachaliou N, Kotsakis A, Agelidou M, Georgoulias V.
Lung Cancer. 2012 Jul;77(1):146-50.

l

«Array-based pharmacogenomics of molecular-targeted therapies in oncology».

Sanoudou D, Mountzios G, Arvanitis DA, Pectasides D.
Pharmacogenomics J. 2012 Jun;12(3):185-96.

l

«Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications».

Soultati A, Mountzios G, Avgerinou C, Papaxoinis G, Pectasides D, Dimopoulos MA, Papadimitriou C.
Cancer Treat Rev. 2012 Aug;38(5):473-83.

l

«Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data».

Mountzios G, Ramfidis V, Terpos E, Syrigos KN.
Clin Lung Cancer. 2011 Nov;12(6):341-9.

l

«A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer».

Mountzios G, Syrigos KN.
Drug Saf. 2011 Mar 1;34(3):175-86.

l

«Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer».

Mountzios I, Bournakis E, Efstathiou E, Varkaris A, Wen S, Chrisofos M, Deliveliotis C, Alamanis C, Anastasiou I, Constantinides C, Karadimou A, Tsiatas M, Papadimitriou C, Bamias A, Dimopoulos MA.
Urology. 2011 Mar;77(3):682-7.

l

«All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer».

Linardou H, Briasoulis E, Dahabreh IJ, Mountzios G, Papadimitriou C, Papadopoulos S, Bafaloukos D, Kosmidis P, Murray S.Cancer Treat Rev. 2011 May;37(3):221-33

Συμμετοχή στη συγγραφή Διεθνών Επιστημονικών Συγγραμμάτων

1. «Targeted Therapies in Oncology»
Editors: Pr. Giuseppe  Giaccone and Pr. Jean -Charles Soria.
Author of Chapter 1: «Overview of existing therapies».
Publisher: Informa Healthcare USA Ó 2007

2.  «European Society for Medical Oncology (ESMO) Handbook of Oncological emergencies».
Editor: Pr. D. Sjivers
Author of Chapter : «Nausea and Vomiting»
Publisher: Taulor and Francis Group Ó 2006

3. «Hellenic Academy of Medical Oncology» Book Series
Editors: Dr. Briasoulis and Dr. Siamantas.
Author of the chapters: «Chemotherapy for early-stage ovarian cancer»
And «Chemotherapy for hormone-refractory prostate cancer».
Publisher: Hellenic Society for Medical Oncology Greece Ó 2007-9

4.  Hellenic  Society of Medical Oncology publication: «Forum of Clinical Oncology»
Author of the chapter: «Pharmacogenomics and Molecular targeted Therapy»
Publisher: Hellenic Society for Medical Oncology Greece Ó 2008